annual cash & cash equivalents:
$118.42M+$19.31M(+19.49%)Summary
- As of today (August 16, 2025), AMRX annual cash & cash equivalents is $118.42 million, with the most recent change of +$19.31 million (+19.49%) on December 31, 2024.
- During the last 3 years, AMRX annual cash & cash equivalents has fallen by -$138.32 million (-53.88%).
- AMRX annual cash & cash equivalents is now -71.46% below its all-time high of $414.86 million, reached on December 1, 2014.
Performance
AMRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$71.54M+$12.36M(+20.88%)Summary
- As of today (August 16, 2025), AMRX quarterly cash & cash equivalents is $71.54 million, with the most recent change of +$12.36 million (+20.88%) on June 30, 2025.
- Over the past year, AMRX quarterly cash & cash equivalents has increased by +$27.77 million (+63.46%).
- AMRX quarterly cash & cash equivalents is now -84.18% below its all-time high of $452.10 million, reached on March 31, 2021.
Performance
AMRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.5% | +63.5% |
| 3 y3 years | -53.9% | -22.2% |
| 5 y5 years | -22.5% | -73.1% |
AMRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +236.2% | -50.5% | +175.4% |
| 5 y | 5-year | -65.9% | +236.2% | -84.2% | +175.4% |
| alltime | all time | -71.5% | +8981.3% | -84.2% | +175.4% |
AMRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $71.54M(+20.9%) |
| Mar 2025 | - | $59.19M(-46.5%) |
| Dec 2024 | $118.42M(+19.5%) | $110.55M(+49.4%) |
| Sep 2024 | - | $74.01M(+69.1%) |
| Jun 2024 | - | $43.77M(-5.9%) |
| Mar 2024 | - | $46.52M(-49.2%) |
| Dec 2023 | $99.11M(+181.3%) | $91.54M(+5.3%) |
| Sep 2023 | - | $86.93M(-20.5%) |
| Jun 2023 | - | $109.28M(-24.5%) |
| Mar 2023 | - | $144.67M(+457.0%) |
| Dec 2022 | $35.23M(-86.3%) | $25.98M(-70.3%) |
| Sep 2022 | - | $87.33M(-5.0%) |
| Jun 2022 | - | $91.98M(-56.3%) |
| Mar 2022 | - | $210.48M(-15.1%) |
| Dec 2021 | $256.74M(-26.0%) | $247.79M(-18.1%) |
| Sep 2021 | - | $302.65M(+8.7%) |
| Jun 2021 | - | $278.31M(-38.4%) |
| Mar 2021 | - | $452.10M(+32.4%) |
| Dec 2020 | $347.12M(+127.1%) | $341.38M(+21.4%) |
| Sep 2020 | - | $281.28M(+5.7%) |
| Jun 2020 | - | $266.14M(-34.3%) |
| Mar 2020 | - | $405.24M(+168.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $152.82M(-30.1%) | $151.20M(-28.9%) |
| Sep 2019 | - | $212.74M(+287.6%) |
| Jun 2019 | - | $54.89M(-14.2%) |
| Mar 2019 | - | $63.95M(-70.0%) |
| Dec 2018 | $218.78M(+180.8%) | $213.39M(+29.2%) |
| Sep 2018 | - | $165.19M(+168.5%) |
| Jun 2018 | - | $61.52M(-17.0%) |
| Dec 2017 | $77.92M(-56.7%) | $74.17M |
| Dec 2016 | $180.13M(-47.1%) | - |
| Dec 2015 | $340.35M(-18.0%) | - |
| Dec 2014 | $414.86M(+0.4%) | - |
| Dec 2013 | $413.13M(+38.2%) | - |
| Dec 2012 | $298.92M(-13.7%) | - |
| Dec 2011 | $346.41M(-0.6%) | - |
| Dec 2010 | $348.40M(+285.5%) | - |
| Dec 2009 | $90.37M(+202.9%) | - |
| Dec 2006 | $29.83M(-46.8%) | - |
| Dec 2005 | $56.08M(+261.7%) | - |
| Dec 2003 | $15.51M(+51.7%) | - |
| Dec 2002 | $10.22M(-71.2%) | - |
| Dec 2001 | $35.47M(+84.4%) | - |
| Dec 2000 | $19.23M(+1374.5%) | - |
| Dec 1998 | $1.30M | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AMRX is $118.42M
What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $414.86M
What is Amneal Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AMRX annual cash & cash equivalents has changed by +$19.31M (+19.49%)
What is Amneal Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMRX is $71.54M
What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $452.10M
What is Amneal Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AMRX quarterly cash & cash equivalents has changed by +$27.77M (+63.46%)